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The Nogo-B receptor (NgBR) is a recently identified
receptor for the N terminus of reticulon 4B/Nogo-B.
Other than its role in binding Nogo-B, little is known
about the biology of NgBR. To elucidate a basic
cellular role for NgBR, we performed a yeast two-
hybrid screen for interacting proteins, using the
C-terminal domain as bait, and identified Niemann-
Pick type C2 protein (NPC2) as an NgBR-interacting
protein. NPC2 protein levels are increased in the
presence of NgBR, and NgBR enhances NPC2
protein stability. NgBR localizes primarily to the
endoplasmic reticulum (ER) and regulates the
stability of nascent NPC2. RNAi-mediated disruption
of NgBR or genetic deficiency in NgBR lead to
a decrease in NPC2 levels, increased intracellular
cholesterol accumulation, and a loss of sterol
sensing, all hallmarks of an NPC2 mutation. These
data identify NgBR as an NPC2-interacting protein
and provide evidence of a role for NgBR in intracel-
lular cholesterol trafficking.
INTRODUCTION
Cholesterol homeostasis is critical for the integrity of numerous
cellular functions. A large proportion of intracellular cholesterol
is derived from low-density lipoprotein receptor (LDL-R)-medi-
ated uptake of exogenous cholesterol (Brown and Goldstein,
1986). After LDL-R-mediated internalization, cholesterol is traf-
ficked from endosomes to lysosomes and ultimately delivered
to the plasma membrane, endoplasmic reticulum (ER), and to
the membranes of other organelles (Ikonen, 2008; Maxfield
and Menon, 2006). Specialized membrane proteins localized to
the ER serve as sterol sensors and thereby regulate both de
novo biosynthesis and uptake of cholesterol (Goldstein et al.,
2006). The absence of proper regulation of sterol trafficking to
the ER results in broad defects in intracellular cholesterol
homeostasis.
Studies of a number of congenital disorders of lipid metabo-
lism have provided critical insights into the cell biology of choles-208 Cell Metabolism 10, 208–218, September 2, 2009 ª2009 Elseviterol trafficking. One disorder of interest is Niemann-Pick type C
disease (NPC), a lysosomal storage disease that results in the
intracellular accumulation of cholesterol and defects in sterol
regulatory responses, leading to progressive neurodegeneration
and liver failure (Kruth et al., 1986; Liscum and Faust, 1987;
Pentchev, 2004). Mutations in either of two genes, NPC1 or
NPC2, result in the NPC phenotype (Carstea et al., 1997; Loftus
et al., 1997; Naureckiene et al., 2000). NPC1 is a polytopic trans-
membrane protein that resides primarily in late endocytic
organelles and contains an intraluminal loop to which cholesterol
binds (Infante et al., 2008a; Scott and Ioannou, 2004). NPC2 is
a soluble glycoprotein (Naureckiene et al., 2000) that binds
cholesterol with nanomolar affinity and is thought to function
by transferring cholesterol between membranes (Cheruku
et al., 2006; Friedland et al., 2003; Ko et al., 2003). In the absence
of NPC1 or NPC2, the efficiency of cholesterol egress from the
lysosomal compartment is impaired, the ER does not readily
sense LDL-derived cholesterol, and LDL uptake and cholesterol
biosynthesis continue unabated (Liscum et al., 1989). These
phenotypic similarities have led to the proposal that both genes
function in the same pathway (Sleat et al., 2004). The recent
development of in vitro assays for measurements of NPC1 and
NPC2 sterol transfer has provided insights into the mechanisms
by which NPC1 and NPC2 may transfer cholesterol at the endo-
somal level (Babalola et al., 2007; Infante et al., 2008b). Despite
these important advances, however, a paucity of information
exists concerning the regulation of NPC2 protein function.
Our group discovered that the reticulon 4B, termed Nogo-B, is
highly expressed in the ER and in caveolin-1-enriched microdo-
mains (CEM) in endothelial cells (EC) and vascular smooth
muscle cells (VSMCs) (Acevedo et al., 2004). A screen for a
receptor for the N-terminal portion of Nogo-B resulted in the char-
acterization of a gene product named Nogo-B receptor (NgBR)
(Miao et al., 2006). NgBR expression is necessary for Nogo-B-
induced chemotaxis and morphogenesis of EC in vitro. Other
than binding Nogo-B, the basic functions of this gene product
are not known.
Here, we report that NPC2 is an NgBR-interacting protein as
identified in a yeast two-hybrid screen. The interaction is recapit-
ulated in mammalian cells, and coexpression of NgBR with NPC2
enhances NPC2 core protein stability, whereas loss of NgBR
decreases NPC2 protein levels. In addition, loss of NgBR using
siRNA or via gene targeting results in cellular phenotypeser Inc.
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Figure 1. NgBR Interacts with and Stabilizes NPC2
(A) NgBR interacts with NPC2 in mammalian cells. CHO cell lines stably expressing either vector alone (Vector), HA-tagged, full-length NgBR (NgBR), or an
HA-tagged, truncated form of NgBR lacking the C-terminal 158 amino acids (NgBRDC) were transfected with myc-tagged NPC2. HA-tagged proteins were
immunoprecipitated from lysates and subjected to western blot analysis using anti-myc and anti-HA antibodies.
(B) The same CHO cell lines in (A) were transfected with increasing amounts of plasmids encoding NPC2-myc or b-gal (0.5 ug–2 ug).
(C) Conditioned media from CHO-Vector and CHO-NgBR transfected with NPC2-myc was collected, and NPC2-myc was immunoprecipitated from the media
using anti-myc antibodies.
(D) Pulse-chase analysis of NPC2. CHO cell lines were transfected with NPC2-myc and subjected to 35S-Met/Cys incorporation for half-life determination of
NPC2 in the absence and presence of NgBR expression. Error bars represent ± SE of pooled data from three independent experiments.
(E) NgBR knockdown and NPC2 levels. HepG2 and EA.hy926 cells were incubated with RNAi directed against NgBR for 48 hr. Cells were lysed, and lysates were
blotted for endogenous NgBR, NPC2, and Cathepsin D.
(F) Analysis of NPC2 degradation. NgBR knockdown was performed as in (E) in the absence or presence of proteasome inhibitor (MG132, 5 mM, 24 hr or lacta-
cystin, 5 mM, 24 hr). After 48 hr of RNAi treatment, cells were lysed and lysates blotted for endogenous NgBR, NPC2, and Cathepsin D.reminiscent of NPC disease, including accumulation of free
cholesterol and upregulation of LDL uptake consistent with
a defect in cholesterol trafficking to the ER. These studies support
a role for NgBR as an NPC2-interacting protein and suggest
avenues for enhancing NPC2 protein stability and thereby influ-
encing the regulation of intracellular cholesterol trafficking.
RESULTS AND DISCUSSION
Evidence of an NgBR-NPC2 Interaction
Analysis of the primary sequence of NgBR (Figure S1A available
online) reveals a single C-terminal domain with homology to
cis-isoprenyltransferase (cis-IPTase). cis-IPTase domains bind
isoprenyl lipids and catalyze the condensation of isopentenyl
diphosphate to farnesyl diphosphate to form long-chain poly-
prenyl diphosphates. Previous studies using partially purified
NgBR showed that it lacks cis-IPTase activity (Miao et al.,
2006). In order to gain insights into NgBR function, we used
the C-terminal domain of NgBR as bait and screened a human
heart cDNA expression library in a yeast two-hybrid assay. AfterCell Mseveral rounds of screening and selection, unique clones were
isolated, and one of the strongest interactions was seen between
the C terminus of NgBR and NPC2 as measured by a-galactosi-
dase secretion (Figures S1B and S1C). These data support the
previously detected interaction between NPC2 and human
dehydrodolichyl disphosphate synthase (DHDDS, also referred
to as human cis-isoprenyltransferase [hCIT]) (Kharel et al.,
2004), the only other mammalian protein characterized thus far
with a cis-IPTase domain (Shridas et al., 2003). However, the
functional relevance of the DHDDS-NPC2 interaction remains
unknown.
The interaction between the cis-IPTase domain in NgBR and
full-length NPC2 was confirmed in mammalian cells by immuno-
precipitation experiments. Transfection of NPC2-myc into CHO
cells stably expressing either vector alone (Vector), NgBR-HA
(NgBR), or a deletion mutant of NgBR that lacks the C-terminal
cis-IPTase domain (NgBRDC) followed by immunoprecipitation
of NgBR-HA demonstrates a clear interaction between NPC2
and NgBR that is absent in cells expressing NgBRDC (Figure 1A).
We also tested the idea that the previously described interactionetabolism 10, 208–218, September 2, 2009 ª2009 Elsevier Inc. 209
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influence the NgBR-NPC2 interaction. Addition of recombinant
AmNgB to CHO-NgBR cells had no effect on the interaction
between NgBR and NPC2, suggesting that NgBR has a distinct
subcellular role independent of AmNgB.
Because NPC2 is a secreted glycoprotein, we examined
NgBR topology using several approaches. Initially, we cloned
the hNPC2 Asn58 glycosylation site in frame at the N (‘‘N-glyco’’)
and C termini (‘‘C-glyco’’) of NgBR (Figure S2A). We also cloned
this tag onto a well-characterized peripheral membrane protein,
endothelial nitric oxide synthase (eNOS), as a negative control.
Expression of the N- and C-glyco mutants of NgBR resulted in
mobility shifts by SDS-PAGE that were sensitive to Endoglycosi-
dase H (EndoH) treatment, suggesting that a proportion of these
regions of NgBR are luminally oriented. Treatment of both WT
and C-glyco eNOS did not show any appreciable differences in
mobility (Figure S2B). We further addressed membrane topology
of NgBR by limited proteolysis experiments (Hua et al., 1995).
We cloned a myc epitope tag at the extreme N terminus of
NgBR and analyzed loss of this epitope after trypsin digestion
(Figure S2C). In the absence of detergent, the luminal ER chap-
erone Grp94 is not cleaved to an appreciable extent by trypsin;
however, when detergent is present, the membrane is permeabi-
lized, and Grp94 is accessible to protease. Analysis of myc and
HA (N and C termini of NgBR, respectively) shows that a propor-
tion of these epitopes are oriented luminally, as the accessibility
of these epitopes to trypsin is enhanced in the presence of deter-
gent. These data suggest that NgBR conforms to a topology
different from that suggested by the initial bioinformatic analysis,
in that both the N and C termini can be arranged with a luminal
orientation.
Analysis of the primary sequence of NgBR using the SignalP
server (Bendtsen et al., 2004) results in the possibility of either
a signal peptide (probability = 0.262) or a signal anchor (an
uncleaved signal peptide; probability = 0.718) that consists of
amino acids 1–23 from the N terminus of NgBR. We took two
approaches to distinguish between these possibilities. First,
we utilized the myc-NgBR-HA construct described above to
assess cleavage of the N-terminal 23 amino acids. If any portion
of the NgBR N terminus is cleaved by signal peptidase, then
loss of the myc epitope should occur and thus be undetectable.
SDS-PAGE analysis of myc-NgBR-HA showed that the myc
epitope remains intact, and myc-NgBR-HA migrates with slightly
slower mobility than NgBR-HA (Figure S2D), providing evidence
of a potential signal anchor motif at the N terminus of NgBR.
In addition, we reasoned that, if NgBR contains a cleaved
signal peptide, then deletion of the N-terminal 23 amino acids
should result in a protein that migrates with the same mobility
as WT NgBR by SDS-PAGE (Figure S2E). In fact, deletion of
this N-terminal region of NgBR resulted in a protein that migrated
faster than WT NgBR (Figure S2F), supporting the argument that
this region remains intact in WT NgBR and is not a cleaved signal
peptide. These data provide evidence that NgBR is not a
canonical type I transmembrane protein, as originally predicted
by bioinformatics analysis, and is atypical in its membrane
orientation. Collectively, these data support the conclusion
that the C-terminal region of NgBR is necessary for the NgBR-
NPC2 interaction in mammalian cells and confirm the yeast
two-hybrid results.210 Cell Metabolism 10, 208–218, September 2, 2009 ª2009 ElsevieWhile conducting the above coimmunoprecipitation experi-
ments, we observed a significant and reproducible increase in
ectopically expressed NPC2 in CHO-NgBR cells relative to
CHO-Vector or CHO-NgBRDC cells. As the plasmid expressing
NPC2 is under the control of a CMV promoter, a plausible expla-
nation for the increase in NPC2 levels is that NgBR decreases the
turnover of NPC2 protein. Indeed, increasing the concentration
of NPC2-myc dose dependently enhanced the levels of NPC2-
myc in lysates from CHO-NgBR cells, but not in lysates from cells
expressing either vector alone or NgBRDC (Figure 1B). More-
over, levels of NPC2 secreted into the media of CHO-NgBR
were greatly enhanced compared to CHO cells expressing
vector alone (Figure 1C). In order to examine the possible effects
of NgBR on NPC2 protein stability, we performed pulse-chase
experiments by expressing NPC2 in the absence or presence
of NgBR. The t1/2 of NPC2 in the absence of NgBR was 3.5 hr,
and the t1/2 of NPC2 in the presence of NgBR was 5.1 hr, reflect-
ing an almost 50% increase in NPC2 stability (Figure 1D).
The preceding experiments were performed in a heterologous
system in which both NgBR and NPC2 were ectopically ex-
pressed. In order to confirm these results in cells that express
high endogenous levels of both NgBR and NPC2, we used
HepG2 cells (a hepatocarcinoma cell line) and EA.hy926 cells
(EA.hy, a hybridoma cell line created by fusion of HUVEC and
A549) and employed an RNAi-mediated approach to decrease
NgBR expression. siRNA directed against NgBR reduces
NgBR levels by 80%–90% (Figure 1E), and the loss of NgBR
reduces endogenous NPC2 expression in both cell lines (the
loss of NgBR reduces NPC2 levels by 35.5% ± 5.2% and
49.3% ± 12.2% in HepG2 and EA.hy926 cells, respectively (n =
5 independent experiments). In order to assess whether the
loss of NgBR influenced the levels of another endosomal/lyso-
somal glycoprotein, we also probed for another soluble lyso-
somal glycoprotein, cathepsin D. Levels of cathepsin D remain
unaffected by loss of NgBR, suggesting a specific effect of
NgBR expression on NPC2 stability. In order to gain insight
into the mechanism by which NgBR regulates NPC2 stability,
we tested the proteasomal dependence of NPC2 degradation.
Treatment of cells with proteasome inhibitors MG132 or lacta-
cystin prevented the loss of NPC2 following NgBR knockdown
(Figure 1F). Collectively, these data suggest that NgBR expres-
sion is necessary for NPC2 stability.
The Interaction between NgBR and NPC2 Occurs
in a Prelysosomal Compartment
In order to gain further insights into the interaction between
NgBR and NPC2, we assessed NgBR and NPC2 colocalization
by immunofluorescence. Detection of endogenous NPC2 by
immunofluorescence is dependent on the usage of Bouin’s fixa-
tive for reliable detection (Zhang et al., 2003). Detection of NgBR
is limited to HA-tagged NgBR using antibodies directed against
the HA epitope in order to maintain compatibility with Bouin’s
fixation. Endogenous NPC2 has been reported previously to
localize to lysosomal, late endosomal, and trans-Golgi network
(TGN) compartments (Berger et al., 2007; Naureckiene et al.,
2000; Zhang et al., 2003). NgBR-HA colocalizes with NPC2
both in punctuate structures and in a diffuse perinuclear
compartment (Figure 2A). In agreement with previous reports,
endogenous NPC2 colocalizes to a large extent with cathepsinr Inc.
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NgBR Interacts with NPC2D (Figure 2B). NgBR-HA, however, does not colocalize with
cathepsin D, suggesting an alternate subcellular compartment
in which the NgBR-NPC2 interaction takes place (Figure 2C).
We tested a variety of organelle markers for colocalization with
NgBR-HA and determined that ER markers such as protein
disulfide isomerase (PDI) and calnexin exhibit the highest degree
of colocalization (Figure 2D). NPC2 contains a canonical signal
peptide and is a soluble luminal glycoprotein, thus a fraction of
NPC2 should be present within the ER lumen during its biosyn-
thesis. In order to ascertain whether any degree of similar
compartmentalization between NgBR-HA and NPC2 exists at
steady state, we colabeled cells for NPC2 and PDI. NPC2
partially colocalizes with PDI, suggesting that the ER is one
compartment in which the NgBR and NPC2 interaction might
occur (Figure 2E).
We sought an independent, biochemical approach to more
rigorously address the localization of NgBR in the context of
these studies. Given the enrichment of NgBR in the ER compart-
ment, we utilized a recently described approach to purify ER
membranes from cultured cells using a continuous iodixanol
gradient separation of ER and lysosomal membranes (Radhak-
rishnan et al., 2008). As seen in Figure 3A, the ER marker calnexin
predominantly localizes to the denser regions of the iodixanol
gradient (designated as region ‘‘2’’ in Figure 3), whereas the
lysosomal marker cathepsin D is almost exclusively present
in the floating membrane layer (designated as region ‘‘1’’ in
Figure 3). NPC2 again cofractionated with cathepsin D as
expected; however, the levels of endogenous NgBR were
beyond detection due to dilution of the fractions. In order to
assess the fractionation of NgBR, we ectopically expressed
a FLAG-tagged NgBR cDNA and determined that NgBR shows
a pattern of fractionation similar to calnexin (Figure 3B) and
that the expression of NgBR enhanced the levels of endogenous
NPC2 in regions 1 and 2 of the gradient. Because we could not
detect NPC2 in region 2 of the fractions in the absence of ectopic
NgBR expression (Figure 3A) yet could detect NPC2 in these
regions of the gradient in the presence of NgBR, these data
suggest that forced expression of NgBR may result in the
appearance of NPC2 in the ER to a more appreciable extent.
We tested this hypothesis by performing immunofluoresence in
cells expressing either full-length NgBR or the C-terminal trunca-
tion mutant of NgBR that does not bind NPC2. In cells trans-
fected with a control plasmid, NPC2 displays a punctate pattern
that does not colocalize with the ER marker PDI (Figure 3C). In
cells overexpressing WT NgBR, NPC2 exhibits a more reticular
distribution coupled with the same punctate pattern seen in
control transfected cells (Figure 3D). This distribution of NPC2
is dependent on the presence of the C-terminal region of
NgBR, as cells expressing NgBRDC display a pattern of NPC2
distribution similar to control (Figure 3E). These results are
unlikely to be explained by nonspecific effects of overexpres-
sion, as transfection of the protein palmitoyltransferase DHHC3
(Fernandez-Hernando et al., 2006) also results in a pattern of
NPC2 distribution similar to control plasmid transfected cells
(Figure 3F). These data bolster the idea that NgBR functions to
stabilize NPC2 during transit in the ER.
Our previous data showing that NPC2 protein levels are
enhanced in the presence of NgBR allowed for further biochem-
ical approaches to test this hypothesis. We tested the stage atCell Mwhich the NgBR-NPC2 interaction occurs by using several
approaches. We blocked NPC2 glycosylation with tunicamycin
in the presence or absence of NgBR expression followed by
cell lysis and immunoblotting for NPC2. Surprisingly, expression
of NgBR increases NPC2 core protein levels in the presence of
tunicamycin (Figure 4A), suggesting that NgBR functions to
stabilize nascent NPC2. In order to further address the stage at
which NgBR affects NPC2, we mutated Asn39 (of mature
NPC2) to Gln (NPC2N58Q). NPC2N58Q has been shown previously
to prevent proper targeting of NPC2 to the lysosome, presum-
ably by interfering with a mannose-6-phosphate receptor
(MPR)-dependent mechanism (Chikh et al., 2004; Liou et al.,
2006). NPC2N58Q levels are also higher in the presence of
NgBR (Figure 4B), again suggesting a role for NgBR in stabilizing
an extralysosomal form of NPC2. We next tested the possibility
that NgBR might influence lysosomal NPC2 levels in a more
direct manner. As has been shown previously, NPC2 is a
secreted glycoprotein, and conditioned medium from cells
expressing NPC2 can functionally rescue cholesterol trafficking
defects in cells deficient in endogenous NPC2 expression,
providing strong evidence for internalization of exogenous
NPC2 into the lysosomal compartment (Naureckiene et al.,
2000; Ko et al., 2003). We collected and concentrated condi-
tioned medium from CHO cells transfected with myc-tagged
NPC2 and then incubated cells treated with Ctrl RNAi or NgBR
RNAi for the indicated times (Figure 4C). Rather than result in
loss of lysosomal NPC2 stability, downregulation of NgBR in
this context seemed to slightly enhance NPC2 uptake. This
effect was not seen in control experiments in which U18666A
(a drug that induces cholesterol sequestration in late endo-
somes/lysosomes and mimics an NPC phenotype) was used
as a control for accumulation in the lysosomal compartment (Fig-
ure 4C). This offers the interesting possibility that loss of NPC2 at
the level of the ER may activate mechanisms to augment the
uptake and storage of lysosomal NPC2. Finally, to test whether
blockade of ER-Golgi trafficking with brefeldin A (BFA) would
influence NPC2 stability, we treated control or NgBR-expressing
CHO cells with different concentrations of BFA. Interestingly,
BFA further enhanced the stabilizing effect provided by NgBR
(Figure 4D). Coupled with the immunofluorescence results, these
data provide evidence of an interaction between NgBR and
NPC2 occurring in a prelysosomal compartment.
Evidence of a Role for NgBR in Intracellular Cholesterol
Trafficking
Due to the accumulation of cholesterol that occurs with loss of
NPC2 expression, we sought to determine whether a similar
phenotype exists with loss of NgBR. In order to examine whether
reduction of endogenous NgBR affects cholesterol trafficking,
we treated HepG2 cells with control siRNA (Ctrl RNAi), NgBR
siRNA (NgBR RNAi), or U18666A (as a positive control to induce
an NPC phenotype) stained with filipin, and free cholesterol
pools were examined by fluorescence microscopy. NgBR
RNAi-treated cells exhibit increased free cholesterol levels, as
shown by the higher intensity of filipin fluorescence relative to
Ctrl RNAi-treated cells (Figure 5A). These data suggest that
NgBR influences cellular cholesterol trafficking and that the
lack of NgBR expression results in accumulation of free choles-
terol. In addition, we derived fibroblasts (MEFs) from WT andetabolism 10, 208–218, September 2, 2009 ª2009 Elsevier Inc. 211
Cell Metabolism
NgBR Interacts with NPC2
212 Cell Metabolism 10, 208–218, September 2, 2009 ª2009 Elsevier Inc.
Cell Metabolism
NgBR Interacts with NPC2Figure 3. Expression of NgBR Increases Levels of ER-Associated NPC2
(A and B) ER membrane fractionation with iodixanol was performed as described by Radhakrishnan et al. (see Supplemental Experimental Procedures). ER
versus lysosomal localization was assessed by fractionation of HEK293T cells over an iodixanol gradient. Cells in (A) contain endogenous levels of NPC2 and
NgBR; cells in (B) contain endogenous NPC2 but overexpressed NgBR. Fraction 1 is defined as a mixture of lysosomes, peroxisomes, and ER, and fraction 2
is defined as purified ER (Radhakrishnan et al., 2008).
(C–F) COS cells transfected with control plasmid (C), WT NgBR-HA (D), NgBRDC-HA (E), or DHHC3-HA (F) were fixed with Bouin’s fixative and stained with anti-
NPC2, anti-PDI, and anti-HA antibodies followed by secondary antibodies as described in the Experimental Procedures. Scale bar, 10 mm.NgBR+/ ES cells and assessed free cholesterol levels by filipin
staining. NgBR+/ MEFs exhibit an increased level of filipin fluo-
rescence intensity relative to WT MEFs (Figure 5B), providing
genetic support for a role for NgBR in intracellular cholesterol
trafficking. To address the possibility that Nogo-B may regulate
these NgBR-dependent defects in cholesterol trafficking, we
stained Nogo-A/B double knockout fibroblasts with filipin. No
appreciable differences in free cholesterol levels were observed
in Nogo-A/B knockout cells (Figure S3), again suggesting that
the NgBR-NPC2 interaction is independent of Nogo-A or -B.
The siRNA sequence used in the preceding experiments
targets the 30 untranslated region (UTR) of the NgBR transcript,
an approach that allows for the rescue of cells by expression
of NgBR lacking the 30 UTR (Miao et al., 2006). We exploited
these sequence differences through introduction of an RNAi-
resistant NgBR construct in cells treated with NgBR RNAi.
Transduction of cells with adenoviral NgBR (Ad-NgBR) alleviates
the increase in free cholesterol and the reduction in NPC2 levels
seen after treatment with NgBR RNAi (Figure 5C). In order to
address the mechanism by which this accumulation of choles-
terol occurs, we treated cells with diminished NgBR with condi-
tioned media collected from cells overexpressing secreted
NPC2. Exogenous NPC2, but not mock-transfected conditioned
media nor media collected from cells expressing NPC2N58Q,
rescued the increase in free cholesterol seen with NgBR RNAi
treatment (Figure 5D), suggesting that this effect is NPC2 depen-
dent. Efforts to understand the basis of NPC disease have led to
the discovery that the NPC phenotype is, in part, due to defectsCell Min sterol trafficking to sites of oxysterol biosynthesis (Frolov et al.,
2003; Zhang et al., 2008). To address the question of whether
NgBR might function in a similar manner, we incubated NgBR
RNAi-treated cells with 25-hydroxycholesterol (25-HC) and
again stained with filipin. Cholesterol accumulation seen after
NgBR RNAi treatment was alleviated by incubation with 25-HC
(Figure 5E) as shown previously for cells deficient in NPC2 func-
tion by Ory and colleagues (Frolov et al., 2003), lending further
credence to the hypothesis that similar sterol trafficking defects
occur with loss of NgBR or NPC2.
NgBR Is Important for Proper Maintenance of Sterol
Sensing
Fibroblasts from Niemann-Pick type C patients exhibit defects in
sterol sensing as a result of the cholesterol accumulation that
occurs upstream of the ER resident sterol-sensing machinery
(Liscum and Faust, 1987). In order to determine whether NgBR-
dependent sterol trafficking defects lead to dysregulation of
sterol sensing in a manner reminiscent of NPC2 disease, we
reduced NgBR levels with RNAi and assessed sterol responsive-
ness. Initially, we assessed the relatively acute suppression of
SREBP cleavage that occurs with addition of exogenous LDL to
cells incubated in the absence of lipoproteins in the media. As
seen in Figure 6A, induction of SREBP cleavage occurs when
cells are cultured in the absence of lipoproteins (lipoprotein defi-
cient serum, LPDS). This cleavage is partially suppressed when
exogenous LDL is added to the medium (Figure 6A, +nLDL).
However, knockdown of NgBR or treatment with U18666AFigure 2. Evidence Supporting Localization of NgBR and NPC2 in a Prelysosomal Compartment
(A–E) HeLa cells transfected with NgBR-HA were fixed and stained with antibodies against HA, NPC2, Cathepsin D, and PDI using Bouin’s fixative for detection of
endogenous NPC2. Scale bar, 10 mm.etabolism 10, 208–218, September 2, 2009 ª2009 Elsevier Inc. 213
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(A) CHO cell lines (see Figure 1D) were transfected with NPC2 and incubated for 24 hr followed by treatment with 5 ug/ml tunicamycin (TN) for 6 hr.
(B) WT NPC2-myc or NPC2N58Q-myc was transfected into CHO cell lines, and levels of NPC2-myc were assessed by western blotting.
(C) After 48 hr of treatment with Ctrl RNAi or RNAi directed against NgBR, EA.hy cells were treated for the indicated times with 1% (final concentration, vol/vol)
concentrated conditioned medium from CHO cells transfected with NPC2-myc. A subset of Ctrl RNAi-treated cells was pretreated with U18666A (1 mM, 8 hr) prior
to addition of exogenous NPC2.
(D) CHO cells stably expressing a vector control (Vector) or full-length NgBR (NgBR) were transfected with myc-tagged NPC2. At 24 hr posttransfection, cells
were treated with the indicated amounts of brefeldin A for 8 hr and lysed, and immunoblotting was performed for detection of NPC2 levels.abrogated this suppressive effect of LDL on SREBP cleavage.
Seeking to determine the functional consequence of this dysre-
gulation, HepG2 cells were treated with Ctrl RNAi or NgBR
RNAi, the biosynthetic pool of cholesterol was labeled using
[14C]-acetate, and de novo cholesterol biosynthesis was
measured. Knockdown of NgBR expression leads to an
enhanced rate of cholesterol synthesis relative to Ctrl RNAi-
treated cells (Figure 6B). Next, we assessed another index of
sterol responsiveness by measuring the specific uptake of DiI-
labeled LDL. EA.hy cells treated with Ctrl RNAi exhibit a dose-
dependent decrease in LDL uptake when incubated for 48 hr in
the presence of increasing concentrations of nLDL (data not
shown). However, loss of NgBR expression leads to diminished
sterol sensitivity, as DiI-LDL uptake is increased upon NgBR214 Cell Metabolism 10, 208–218, September 2, 2009 ª2009 Elsevieknockdown despite preincubation of cells with nLDL prior to
DiI-LDL treatment (Figure 6C). Moreover, this increase in uptake
is mirrored by an increase in cell surface binding of LDL
(Figure 6D), suggesting that more LDL-R is present at the cell
surface in the absence of NgBR expression. Indeed, HepG2 cells
treated with NgBR siRNA exhibit increased levels of total and
surface LDL-R (Figures S4B and 6E, respectively).
In order to determine the relative specificity of the effects
described above, we performed rescue experiments with an
NgBR cDNA construct lacking the RNAi target sequence. Treat-
ment of HepG2 with NgBR RNAi leads to 90% loss of NgBR
expression, whereas RNAi against NgBR in cells stably express-
ing the coding sequence alone leads to loss of endogenous
NgBR (E), but not transfected NgBR (R) (Figure 6F). Indeed, cellsr Inc.
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NgBR Interacts with NPC2Figure 5. Loss of NgBR Induces Free Cholesterol Accumulation in Cells
(A and B) (A) EA.hy926 cells or (B) NgBR+/ fibroblasts (MEFs) were incubated with nonsilencing RNA (Ctrl RNAi) or small interfering RNA directed against NgBR
(NgBR RNAi) for 48 hr. U18666A (1 uM, 8 hr) was used as a positive control for inhibition of cholesterol trafficking. Cells were fixed and stained for free cholesterol
with filipin as described in the Experimental Procedures. Scale bar, 20 mm.
(C) EA.hy926 cells were infected with an adenoviral construct expressing GFP or with adenovirus encoding NgBR (Ad-NgBR) for 24 hr, followed by incubation with
Ctrl RNAi or NgBR RNAi for 48 hr. Cells were then fixed and stained for free cholesterol as in (A) and (B).
(D) Conditioned medium from CHO cells transfected with NPC2-myc was concentrated and added to EA.hy926 cells incubated with Ctrl RNAi or NgBR RNAi for
24 hr.
(E) EA.hy926 cells treated with Ctrl RNAi or NgBR RNAi were incubated with 2.5 mM 25-hydroxycholesterol (25-HC) for 18 hr followed by fixation and staining with
filipin. (*p < 0.05).stably expressing transfected NgBR did not show any appre-
ciable increase in LDL-R expression after siRNA treatment
(Figures S4C and 6G, total and surface LDL-R, respectively),
proving the specificity of the RNAi effects seen in prior experi-
ments. We also treated cells with 25-HC, as in the filipin staining
experiments, in order to further address the mechanistic basis
for the increase in LDL-R levels. Incubation of EA.hy cells with
25-HC results in a dramatic decrease in both total (Figure S4D)
and surface (Figure 6H) LDL-R expression in cells treated with
NgBR RNAi. Next, we performed analogous experiments in
primary cultures of human skin fibroblasts because the above
experiments were performed in immortalized cell lines. Fibro-
blasts treated with NgBR RNAi again exhibited increased intra-
cellular cholesterol accumulation (Figure S5A) and diminished
suppression of SREBP cleavage in the presence of LDL choles-
terol (Figure S5B), providing support for a role for NgBR in
cholesterol homeostasis. Thus, the loss of NgBR leads to dysre-Cell Mgulation of sterol homeostasis consistent with the accumulation
of free cholesterol as occurs in NPC2 disease.
In summary, we have identified a function for NgBR as an
NPC2 binding partner that regulates NPC2 stability/turnover.
Our data suggest that the NgBR cis-IPTase homology domain
is crucial for its interaction with NPC2 in yeast and heterologous
mammalian expression systems. These data are particularly
compelling in light of the previously described interaction
between NPC2 and the cis-IPTase domain of DHDDS. Future
efforts will seek to define a possible relationship between
NPC2, NgBR, and DHDDS.
Although it is well appreciated that the functional relationship
between NPC1 and NPC2 is critical for cholesterol trafficking,
our data provide compelling evidence for an unappreciated
mode of NPC2 regulation via this newly described interaction.
Interestingly, NgBR partially colocalizes with NPC2 in the ER
and enhances the levels of nascent NPC2 protein. Our resultsetabolism 10, 208–218, September 2, 2009 ª2009 Elsevier Inc. 215
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Figure 6. NgBR Expression Is Necessary for Proper Regulation of Cellular Cholesterol Homeostasis
(A) SREBP-2 cleavage assay. EA.hy cells were treated with Ctrl RNAi or NgBR RNAi for 12 hr followed by addition of FBS or lipoprotein-deficient serum (LPDS) for
a further 48 hr. Cells either remained in LPDS or were treated with 20 mg/ml nLDL for 10 hr prior to lysis.
(B) Cholesterol biosynthesis in HepG2 cells. HepG2 were treated with Ctrl RNAi or NgBR RNAi for 48 hr. Cholesterol biosynthesis was examined as described in
the Experimental Procedures.
(C and D) EA.hy926 cells were treated with Ctrl RNAi or NgBR RNAi, and LDL uptake and surface LDL binding measurements were performed as described in the
Experimental Procedures.
(E) EA.hy926 cells treated with Ctrl RNAi or NgBR RNAi were subjected to analysis of LDL-R expression as described in the Experimental Procedures.
(F) HepG2 cell line stably expressing full-length NgBR. Ctrl RNAi or NgBR RNAi was incubated with HepG2 cells stably expressing either empty vector (V) or an
RNAi-resistant NgBR construct (NGBR).
(G) Surface LDL-R expression was analyzed in HepG2 stable cell lines after treatment with NgBR RNAi as described in the Experimental Procedures.
(H) EA.hy926 cells were treated with RNAi for 24 hr, followed by incubation with lipoprotein-deficient serum supplemented with nLDL in the absence or presence
of 2.5 mM 25-hydroxycholesterol (25-HC) for 24 hr. Surface LDL-R expression (H) was analyzed by flow cytometry as described in the Experimental Procedures.
*p < 0.05; **p < 0.01.are in agreement with numerous studies that have shown NPC2
to be primarily localized to a lysosomal compartment at steady
state; however, our data suggest that an additional level of regu-
lation has evolved to ensure stability of NPC2 at its earliest steps
of entry into the secretory pathway. The idea that a unique chap-
erone function may be conferred by noncanonical binding events
within the ER is not unprecedented and has been suggested for
other proteins (Ju et al., 2008).
The effects of NgBR on NPC2 described herein appear to be
independent of the only other described binding partner for
NgBR, Nogo-B. Loss of NgBR genetically or using siRNA leads
to cholesterol accumulation, which, in turn, results in defects in216 Cell Metabolism 10, 208–218, September 2, 2009 ª2009 ElsevieER sterol sensing, both of which are phenotypic hallmarks of
mutations in NPC2. Thus, these data reveal insights into NPC2
trafficking, protein stability, and cholesterol homeostasis and
raise the possibility that loss-of-function mutations in NgBR
may promote defects in cholesterol metabolism.
EXPERIMENTAL PROCEDURES
Description of methods pertaining to yeast two-hybrid, cell culture, immuno-
precipitation, and western blot analysis, as well as cell fractionation and
protease protection assays are presented within the Supplemental Experi-
mental Procedures.r Inc.
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Express [35S] protein labeling mix (NEG-072) was from Perkin Elmer; MG132,
lactacystin, U18666A, and brefeldin A were purchased from EMD Biosciences;
filipin and Bouin’s fixative were from Sigma; 25-hydroxycholesterol was
purchased from Steraloids, Inc.; EndoH was from New England Biolabs. The
origin of other chemicals and antibodies is described within the Supplemental
Experimental Procedures. cDNA constructs are described with the Supple-
mental Experimental Procedures.
Pulse-Chase Analysis
Pulse-chase studies were performed essentially as described (Liu et al., 1995).
In brief, CHO cells stably expressing either vector alone or full-length NgBR
were cultured in 60 mm plates and transfected with NPC2-myc at 80%
confluency. At 24 hr posttransfection, cells were starved in methionine/
cysteine-free DMEM + 5% dialyzed FCS for 3 hr at 37C. Labeling was per-
formed for 1 hr at 37C with 200 mCi of Express labeling mix (Perkin-Elmer)
added to each plate. After 1 hr of labeling, medium supplemented with
2 mM methionine and cysteine was added for the designated times, after
which cells were lysed and lysates were prepared for immunoprecipitation
with anti-myc antibodies.
Filipin Staining and Immunofluorescence
For detection of intracellular-free cholesterol, cells were fixed in 4% PFA at
room temperature (RT) for 10 min, followed by permeabilization in 0.1% Triton
X-100 for 5 min at RT. Cells were then incubated with filipin (Sigma, diluted
from a stock concentration of 25 mg/ml in DMSO to 50 ug/ml final concentra-
tion in PBS) for 30 min at RT. As a positive control for induction of cholesterol
accumulation, cells were incubated in DMEM + 10% FBS and treated for 8 hr
with 1 mM U18666A (EMD Biosciences) prior to fixation. Relative intensity of
filipin staining was quantified by calculating average pixel intensity using
Adobe Photoshop according to the equation: average filipin intensity = total
intensity above low threshold/number of pixels above low threshold (Pipalia
et al., 2006). For immunofluorescence, HeLa cells were transfected with
pcDNA3-NgBR-HA and fixed with Bouin’s fixative for 1 hr at RT. Fixation
was followed by permeabilization with 0.1% Triton X-100 for 5 min at RT. Cells
were blocked in 5% BSA for 30 min at RT and were incubated overnight with
the following antibodies diluted in 5% BSA: anti-HA (Roche) 1:1000, anti-NPC2
H-125 (Santa Cruz) 1:200, anti-PDI (BD Biosciences) 1:500, and anti-
Cathepsin D (Santa Cruz) 1:200. Primary antibody incubation was followed
by incubation with Alexa-Fluor 488 (1:500), Alexa-Fluor 594 (1:500), or Alexa-
Fluor 647 (1:500) conjugated secondary antibodies for 1 hr at RT. Images were
captured with a Leica TCS SP5 Spectral Confocal Microscope.
Cholesterol Biosynthesis
Metabolic labeling and analysis of cholesterol biosynthesis was performed as
previously described (Fernandez et al., 2002). In brief, HepG2 cells (6 3 106)
were cultured in DMEM + 10% LPDS for 48 hr followed by addition of nLDL
for 4 hr, upon which 40 mCi [2-14C] acetate was added to the medium of
each plate and incubated for 12 hr in order to label the biosynthetic pool of
sterol. At the end of the incubation period, cells were washed with ice-cold
PBS and resuspended in 0.5 ml of 10% (v/v) KOH. [3H] cholesterol was added
as an internal standard. After chloroform:methanol extraction (2:1, v/v), the
lipid extract was further subfractionated into saponifiable and nonsaponifiable
fractions. The nonsaponifiable fraction was resuspended in hexane and sepa-
rated by HPLC using a reverse-phase HPLC with a Luna 5 um pore size C18
column (250 mm 3 4.60 mm; Phenomenex).
LDL Uptake
Native plasma LDL was isolated by preparative sequential ultracentrifugation
of pooled normolipidemic sera from humans after an overnight fast as
described (Calvo et al., 1998). Labeling of LDL with the fluorescence probe
1,10-diotadecyl-3-3-30-30-tetramethylindocarbocyanine perchlorate (DiI) was
carried out according to published methods (Via and Smith, 1986). HepG2
or EA.hy926 cells were cultured in 45% OPTI-MEM / 45% DMEM + 10% fetal
bovine lipoprotein-deficient serum (Intracel, Inc.) with or without addition of
native LDL and containing either Ctrl RNAi or NgBR RNAi for 48 hr prior to addi-
tion of 20 ug/ml DiI-labeled LDL for a 2 hr incubation period to measure uptake.
In order to assess specific uptake of DiI-LDL, control cells were incubated withCell Ma 40-fold excess of unlabeled nLDL, and uptake values from these cells were
subtracted from experimental samples.
LDL-R Expression by FACS
HepG2 cells or EA.hy926 cells were seeded in 60 mm plates at 30% conflu-
ency. After 24 hr of culture, cells were washed twice with PBS, and media
was replaced with OPTI-MEM containing oligofectamine (Invitrogen) and
10 nM siRNA (final concentration) at a 10:1 ratio (oligofectamine:siRNA).
siRNAs used in this study were designed using BIOPREDsi (http://www.
biopredsi.org) and purchased from QIAGEN. The siRNA sequences are: Ctrl
RNAi (AllStars Neg. Ctrl siRNA, QIAGEN), NgBR RNAi (50-AAGGAAATACATA
GACCTACA-30). After 48 hr of incubation with siRNA, cells were washed
with PBS, trypsinized, washed once in growth medium, and resuspended in
blocking buffer (1% BSA + 1% normal goat serum in PBS) at a concentration
of 107 cells/ml. For surface labeling, cells were incubated in blocking buffer for
10 min at RT followed by 5 min on ice. Cells (100 ul, or 106) were incubated on
ice with 1.5 ug of LDL-R primary antibody (LDL-R C7, Santa Cruz) for 45 min.
mIgG2b (1.5 ug) (Santa Cruz) was used as a control. Following incubation with
primary antibody, cells were washed two times with blocking buffer and incu-
bated with FITC-conjugated goat anti-mouse secondary antibody for 30 min
on ice. Cells were again washed twice with blocking buffer and resuspended
in PBS. For total LDL-R analysis, cells were fixed with 4% paraformaldehyde
immediately after removal from the plate for 15 min at room temperature. After
two washes with blocking buffer, cells were permeabilized with 0.1% Triton
X-100 for 15 min at room temperature and again washed two times with block-
ing buffer. After the permeabilization step, cells were stained in an identical
manner as presented above for surface-labeled cells. Flow cytometry was per-
formed using a BD FACsort cell sorter. Data are presented as described in the
figure legend.
Statistical Analyses
Data are expressed as mean ± SE. Statistical comparisons between groups
were performed using Student’s t test or analysis of variance (ANOVA) using
Graphpad Software (La Jolla, CA). Significant differences are indicated in
the figures.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and five
figures and can be found with this article online at http://www.cell.com/
cell-metabolism/supplemental/S1550-4131(09)00199-5.
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